Study reveals how bile acids impact immunotherapy in liver cancer
Immunotherapy is a modern approach to cancer treatment that uses a patient's own immune system to help fight tumors. It...
Study
Liver Cancer Treatment Breakthrough in Global Study
Researchers at Mount Sinai have made a breakthrough in treating a type of liver cancer called hepatocellular carcinoma (HCC). This...
Bleeding rates with severe hemophilia A fall with prophylaxis: Study
Prophylactic, or preventive, treatment with factor VIII (FVIII) replacement therapy for four years reduced annual bleeding rates by 91% for...
Phase 2 Study Evaluates Serplulimab Plus HLX04 as First-Line Treatment for Advanced Hepatocellular Carcinoma
An open-label, multicenter phase 2 study (NCT03973112) conducted in China aimed to investigate the safety and initial effectiveness of serplulimab...
Lancet study has hope for liver cancer: Immunotherapy drug can delay progression in patients who can’t be treated with surgery | Health and Wellness News
Immunotherapy, a form of treatment that uses the body’s immune system to find and fight cancer cells, can delay the...
Study reveals need for better tools to guide kidney failure patients
A systematic review of mortality prediction models for kidney failure patients identified limitations in current tools used to inform treatment...
